Laurus Labs Q4 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
1,087.95
-9.95 (-0.91%)
-9.95 (-0.91%)Volume29.77 K
Updated: Mon 13 Apr, 2026 | 15:58:53
NSE
1,086.65-11.70 (-1.07%)
-11.70 (-1.07%)Volume1.23 M
Updated: Mon 13 Apr, 2026 | 15:25:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Laurus Labs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,410.13 | 1,418.70 | 14.09% | 1,300.43 | 8.44% |
| Depreciation/ Amortization | 110.43 | 120.62 | 4.09% | 102.25 | 8.00% |
| Operating Income | 310.17 | 359.59 | 73.22% | 139.24 | 122.76% |
| Net Income | 233.67 | 251.66 | 153.16% | 75.61 | 209.05% |
| Other Operating Expenses Total | 339.32 | 374.27 | 2.63% | 315.06 | 7.70% |
| Net Income Before Taxes | 312.34 | 326.56 | 139.01% | 107.27 | 191.17% |
| Total Revenue | 1,720.30 | 1,778.29 | 21.57% | 1,439.67 | 19.49% |
| Selling/ General/ Admin Expenses Total | 177.70 | 229.24 | -6.04% | 161.11 | 10.30% |
| Diluted Normalized EPS | 4.33 | 4.65 | 153.27% | 1.40 | 208.72% |